Related Experiment Video
Updated: May 11, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Mixed-effects beta regression for modeling continuous bounded outcome scores using NONMEM when data are not on the
Xu Steven Xu1, Mahesh N Samtani, Adrian Dunne
1Model-Based Drug Development, Janssen Research & Development, 920 Route 202, Raritan, NJ, USA. sxu26@its.jnj.com
NONMEM can now implement mixed-effects beta regression models for bounded clinical data using Nemes
Area of Science:
- Pharmacometrics and Clinical Pharmacology
- Biostatistics and Computational Biology
Background:
- Beta regression models are suitable for bounded continuous outcome scores common in clinical research.
- Implementing these models in NONMEM is challenging due to the absence of built-in gamma functions required for the beta distribution.
- Existing methods often rely on approximations or external software, necessitating an evaluation of NONMEM's capabilities.
Purpose of the Study:
- To implement mixed-effects beta regression models in NONMEM utilizing Nemes' approximation for the gamma function.
- To assess the performance of this NONMEM implementation by comparing it with the established SAS approach.
- To evaluate the accuracy, bias, and computational efficiency of the NONMEM implementation for clinical trial data analysis.
Main Methods:
- Mixed-effects beta regression models were implemented in NONMEM using Nemes' approximation for the gamma function.
- Monte Carlo simulations generated continuous outcomes (0-70) based on a beta regression model in an Alzheimer's disease context.
- Simulations involved 250 subjects with 6 samples per subject over 3 years, repeated for 1000 trials, and compared with SAS using adaptive Gaussian quadrature.
Main Results:
- The NONMEM implementation with Nemes' approximation showed only slightly higher bias and relative Root Mean Square Error (RMSE) compared to SAS.
- Differences in bias and RRMSE for fixed effects, random intercept, and precision parameters were <1-3%; for random slope, <3-7%.
- NONMEM demonstrated significantly shorter run times (1-2 seconds) compared to SAS (20-40 seconds) for the analyzed model and data.
Conclusions:
- NONMEM, with Nemes' approximation of the gamma function, provides comparable parameter estimates to SAS for mixed-effects beta regression models.
- The NONMEM implementation offers a computationally efficient alternative for analyzing bounded continuous outcomes in clinical studies.
- This approach is suitable for modeling disease progression, as demonstrated in the Alzheimer's disease cognitive assessment scale analysis.
Related Concept Videos
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Parametric Survival Analysis: Weibull and Exponential Methods
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Regression Toward the Mean
Kaplan-Meier Approach
Censoring Survival Data
